THREAD and CureClick Partner to Accelerate Recruitment for Decentralized Clinical Trials

Sponsors and CROs can access the power of patient activist-driven crowdsourcing to improve recruitment in DCTs

THREAD, an innovative technology and service provider that enables decentralized clinical research, and CureClick, a community-powered platform that revolutionizes participant recruitment for clinical trials, announced a new partnership focused on engaging social media influencers to increase recruitment outcomes in decentralized clinical trials (DCTs). Combining THREAD’s platform with CureClick’s network of more than 100,000 patient activists and advocates, influencers can now highlight potentially life-saving DCTs within targeted social media networks to achieve increased enrollment, retention and satisfaction rates.

Recommended AI News: Comtech Telecommunications Corp. Awarded $1.5 Million in Orders for Satellite Modems and Optimization Equipment

“We are excited for this partnership to advance recruitment for DCTs,” said Fabio Gratton, CEO of CureClick. “THREAD is the leading DCT provider, and by joining forces, we can better fulfill our mission to help life science organizations recruit patients faster while ensuring they have the best possible experience at every step.”

CureClick increases clinical trial awareness and accelerates patient recruitment by enabling trusted members of online communities to easily find and disseminate accurate, patient-friendly information across their social networks. Through this partnership, CureClick patient activists, or “ambassadors,” will deliver eligible participants to THREAD’s automated participant recruitment and onboarding solution. The result is a frictionless patient experience from study awareness generation through enrollment and beyond.

Recommended AI News: O’Reilly Announces New Diversity and Inclusion Scholarship Program to Encourage and Support the Next Generation of Technology Talent

“We have great admiration for CureClick’s ability to drive exceptional recruitment outcomes through its ambassador network of patient activists,” said John Reites, CEO of THREAD. “Having worked successfully with CureClick on several studies in the past, we are excited to deepen our collective impact on DCTs through a more formal partnership.”

THREAD recently enhanced its DCT platform with a configurable, automated participant recruitment and onboarding solution. This recruitment innovation enables sponsors and CROs to create patient-facing websites that guide potential participants through a simple automated recruitment and onboarding process.

Recommended AI News: Fidelis Care Offers Support, Guidance for Families on Cyberbullying